the efficacy of rifampin prophylaxis ( 20 mg/kg/day in two doses for four days ) in eliminating pharyngeal hemophilus influenzae type b from household contacts of 38 patients with invasive hemophilus disease was evaluated in a prospective , placebo-controlled fashion .
C0035608
rifampin
C0018482
hemophilus disease